Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of the American Academy of Nurse Practitioners|March 13, 2012
Outcomes from the evaluation of an emergency department-based mental health nurse practitioner outpatient service in AustraliaTimothy Wand, Kathryn White, Joanna Patching, et al.
International Journal of MS Care|January 24, 2014
The evolving role of the multiple sclerosis nurse: an international perspectiveTherese Burke, Sara Dishon, Lynn McEwan, et al.
Australian Journal of General Practice|April 1, 2022
The lived experience of multiple sclerosis: Patient insights to guide general practitioner careTherese Burke, Rohan Greenland, Erin Brady, et al.
Frontiers in Public Health|January 10, 2018
The Validity and Reliability Characteristics of the M-BACK Questionnaire to Assess the Barriers, Attitudes, Confidence, and Knowledge of Mental Health Staff Regarding Metabolic Health of Mental Health Service UsersAndrew Watkins, Simon Rosenbaum, Philip B Ward, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 6, 2013
The utility of multimodal evoked potentials in multiple sclerosis prognosticationSudarshini Ramanathan, Kerry Lenton, Therese Burke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2011
Cortical dysfunction underlies disability in multiple sclerosisSteve Vucic, Therese Burke, Kerry Lenton, et al.
Pathology|March 13, 2012
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid improves diagnostic utility for multiple sclerosisMing-Wei Lin, Dan Suan, Kerry Lenton, et al.
Multiple Sclerosis and Related Disorders|August 28, 2023
The multiple sclerosis self-concept change scale: Development and validation of a new measureHolly Emery, Ingrid van der Mei, Christine Padgett, et al.
Clinical Immunology (Orlando, Fla.)|January 15, 2016
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapiesFiona C McKay, Prudence N Gatt, Nicole Fewings, et al.
Pageof 2